| |
| |
|
| Insider
Information: |
Raab Michael |
| Relationship: |
|
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,353,869 |
|
|
Indirect Shares
|
25,364 |
|
|
| Direct
Value |
$9,601,026 |
|
|
|
Indirect Value
|
$173,997 |
|
|
| Total
Shares |
1,379,233 |
|
|
| Total
Value |
$9,775,023 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
16
|
|
Stock
price went up :
|
1
|
11
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
2.2
|
| Percentage
Gain/Loss : |
 276.6%
|
1,415.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardelyx Inc |
ARDX |
President & CEO, Direc... |
2024-05-29 |
1,270,273 |
2024-05-29 |
25,364 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
|
2024-03-05 |
83,596 |
2015-06-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
|
– • – |
2024-03-05 |
4 |
OE |
$2.80 |
$42,000 |
D/D |
15,000 |
83,596 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2015-06-08 |
4 |
D |
$12.65 |
$113,040 |
D/D |
(8,936) |
0 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2017-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,814 |
5,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2017-10-12 |
4 |
OE |
$14.25 |
$142,534 |
D/D |
10,000 |
15,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2017-10-12 |
4 |
AS |
$14.25 |
$142,534 |
D/D |
(10,000) |
5,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-01-02 |
4 |
AS |
$15.00 |
$140,490 |
D/D |
(9,366) |
5,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-01-02 |
4 |
OE |
$15.00 |
$140,490 |
D/D |
9,366 |
15,180 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-04-16 |
4 |
OE |
$10.53 |
$52,650 |
D/D |
5,000 |
10,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-04-16 |
4 |
AS |
$14.41 |
$72,058 |
D/D |
(5,000) |
5,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,081 |
8,895 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2019-06-03 |
4 |
AS |
$11.16 |
$55,776 |
D/D |
(5,000) |
8,895 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2019-06-03 |
4 |
OE |
$7.15 |
$35,750 |
D/D |
5,000 |
13,895 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2019-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
15,145 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2020-06-01 |
4 |
OE |
$2.81 |
$14,050 |
D/D |
5,000 |
20,145 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2020-06-01 |
4 |
AS |
$12.65 |
$63,261 |
D/D |
(5,000) |
15,145 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,855 |
21,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2021-05-18 |
4 |
OE |
$7.56 |
$42,593 |
D/D |
5,634 |
26,634 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,115 |
36,749 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2022-05-02 |
4 |
AS |
$6.99 |
$104,891 |
D/D |
(15,000) |
36,749 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2022-05-02 |
4 |
OE |
$4.79 |
$71,850 |
D/D |
15,000 |
51,749 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,671 |
49,420 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2023-03-17 |
4 |
S |
$11.33 |
$49,943 |
D/D |
(4,408) |
60,012 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2023-03-17 |
4 |
OE |
$3.32 |
$49,800 |
D/D |
15,000 |
64,420 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,584 |
68,596 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2014-12-23 |
4 |
A |
$0.00 |
$0 |
I/I |
27 |
27 |
0 |
- |
|
78 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
